Review on Panton Valentine leukocidin toxin carriage among Staphylococcus aureus

B Shrestha1

  • 1Department of Microbiology, Tri-Chandra Campus, Tribhuvan University, Nepal.

Insights

Panton Valentine leukocidin (PVL) is a toxin produced by Staphylococcus aureus. PVL-positive methicillin-resistant Staphylococcus aureus (MRSA) strains are a growing global health threat, causing severe infections and increasing mortality.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Toxicology

Background:

  • Panton Valentine leukocidin (PVL) is a Staphylococcus aureus virulence factor that creates pores in polymorphonuclear cells.
  • Initially associated with methicillin-susceptible S. aureus, PVL production is now linked to methicillin-resistant S. aureus (MRSA) due to mecA gene acquisition.
  • PVL-positive MRSA represents a significant challenge due to antibiotic resistance and potent toxin production.

Purpose of the Study:

  • To highlight the increasing threat of PVL-positive MRSA globally.
  • To discuss the severe clinical manifestations and high mortality associated with PVL-positive MRSA infections.
  • To emphasize the need for control measures against PVL-positive MRSA, particularly in hospital settings.

Main Methods:

  • Literature review and synthesis of existing data on PVL-positive S. aureus and MRSA.
  • Analysis of reported cases and epidemiological trends of PVL-positive MRSA infections.
  • Clinical case study analysis of severe infections caused by PVL-positive MRSA.

Main Results:

  • PVL-positive MRSA strains have spread globally, causing life-threatening infections in the UK, Europe, USA, and Australia.
  • These superbug strains can cause rapid, fatal infections, even in healthy young individuals, within 24 hours.
  • Associated infections range from skin and soft tissue infections to invasive conditions like necrotizing pneumonia.

Conclusions:

  • PVL-positive MRSA is a virulent, drug-resistant pathogen posing a significant global health risk.
  • The emergence and spread of community-associated PVL-positive MRSA into hospitals increase mortality rates.
  • Urgent control strategies are necessary to prevent widespread hospital-acquired infections by PVL-positive MRSA.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
138
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
139
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
215
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
71
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
82